Dr. Ajit Mahapatra, MD

Dr. Mahapatra practices at Santa Clara Dialysis in Santa Clara, California.

Dr. Mahapatra's NPI, 1699853275, was assigned on November 1, 2006. Dr. Mahapatra graduated from Stanford University School Of Medicine in 2001. Dr. Mahapatra's California license number on file is A79895.

Dr. Mahapatra's primary practice is Santa Clara Dialysis, at 710 Lawrence Expy, Santa Clara, CA 95051 in Santa Clara County. The practice phone is (408) 243-1130.

Dr. Mahapatra's primary practice is Santa Clara Dialysis in Santa Clara, California. Dr. Mahapatra is also affiliated with Santa Clara Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Mahapatra to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahapatra practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mahapatra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mahapatra is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mahapatra's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic kidney disease among the conditions Dr. Mahapatra treats.

CMS data shows 24 Medicare services from Dr. Mahapatra across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $1,684 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Mahapatra in 2024. 75% of them have chronic kidney disease, and 75% have diabetes. Their average risk score is 7.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahapatra's median patient age at 67, with 52% women.

In 2024, Dr. Mahapatra wrote 2,122 Medicare Part D claims for 342 patients. 82% of them were for generic drugs. CMS names the drug for 1,648 of them, across 50 drugs with 11 or more claims each, at $132,847 in total drug cost. In 2023, CMS named 1,535 claims across 47 drugs.

Dr. Mahapatra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Mahapatra, published from 2004 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Fluorescent Dyes, Molecular Structure and Candida albicans. Dr. Mahapatra has published most often in Bioorg Med Chem Lett. Dr. Mahapatra's most frequent co-authors are Vignesh A. Arasu, MD, Jennifer Connolly Boldrick, MD and Mamata Vijayanand Kene, MD.

CMS Open Payments shows 1 general payment to Dr. Mahapatra from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. NxStage Medical, Inc. paid the most, $17.

Dmand AI lists 2 awards for Dr. Mahapatra, most recently Checkbook Top Doc in 2011.

Dr. Mahapatra graduated from Stanford University School Of Medicine in 2001.

Dr. Mahapatra is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.